Daclizumab is used in transplant patients to prevent the body from rejecting a kidney transplant.
How it works
Daclizumab belongs to the class of medications called monoclonal antibodies. It suppresses the activity of the body’s immune system (immunosuppressive agent) thereby preventing the rejection of transplanted kidney by body’s own immune system.
Common side effects
Altered heart rate, Anaphylactic reaction, Blue colour of skin, Purple colour of skin, Decreased blood pressure, Fever, Heart attack, Decreased oxygen level in blood, Increased risk of infection, Increased sweating, Injection site reaction, Limb swelling, Respiratory arrest, Skin rash, Itching, Wheezing
- 1 variant(s)
- Use the medicine with caution if you are an elderly patient or have previously been exposed to daclizumab.
- Take appropriate precautions as daclizumab can reduce the ability of your body to fight infections.
- Do not consume this drug if you are allergic to daclizumab or any of the drug ingredients.
- Tell your doctor if you are pregnant or planning to become pregnant or are breastfeeding.
Frequently asked questions
Q. How does daclizumab work?
Daclizumab suppresses the activity of the body’s immune system (immunosuppressive agent) thereby preventing the rejection of transplanted kidney by body’s own immune system.